Loading...

Home
ETF
RXST

RXST

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

RXST News

U.S. Stocks Mixed; Day One Biopharmaceuticals Shares Surge 20%

Jan 12 2026Benzinga

Planet Labs PBC Secures Nine-Figure Deal with Swedish Armed Forces, Shares Surge 7%

Jan 12 2026Benzinga

RxSight Expects Q4 2025 Revenue of $32.6 Million, Appoints CFO

Jan 11 2026NASDAQ.COM

RxSight Reports $134.5M Revenue for 2025, Announces CFO Transition

Jan 11 2026Globenewswire

RxSight to Present at J.P. Morgan Healthcare Conference on January 13, 2026

Jan 02 2026Globenewswire

RxSight to Present at J.P. Morgan Healthcare Conference on January 13, 2026

Jan 02 2026Newsfilter

RxSight Faces Securities Fraud Investigation Following CFO Departure

Jan 01 2026PRnewswire

RxSight CFO Shelley Thunen Transitions to Consultant Role Until 2026

Dec 23 2025NASDAQ.COM

RxSight CFO Shelley Thunen Transitions, Supporting Company Growth

Dec 22 2025Globenewswire

Ross Stores Reports Impressive Q3 Earnings, Alongside Enviri, Azenta, and Other Major Stocks Rising on Friday

Nov 21 2025Benzinga

Needham Keeps Buy Rating on RxSight and Increases Price Target to $12

Nov 06 2025Benzinga

Medtech Stocks Surge in After-Hours Trading: RxSight, Penumbra, and Evolus Take the Lead

Nov 06 2025NASDAQ.COM

RXSIGHT UPDATE: Bragar Eagel & Squire, P.C. Investigates RxSight, Inc. for Long-Term Shareholders and Urges Investors to Reach Out to the Firm

Oct 08 2025Globenewswire

RxSight, Inc. Shareholders Urged to Reach Out to Levi & Korsinsky by September 22, 2025 to Explore Their Rights – RXST

Sep 22 2025Globenewswire

RXSIGHT FINAL DEADLINE NOTICE: Bragar Eagel & Squire, P.C. Encourages RXST to Reach Out About Class Action Lawsuit

Sep 22 2025Globenewswire

RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces Opportunity for RxSight, Inc. Investors Facing Significant Losses to Head Class Action Lawsuit

Sep 21 2025Globenewswire